CymaBay Therapeutics, Inc. carries a market capitalization of 3.73B, placing it among publicly traded companies globally.
| Market Cap | 3.73B |
| Enterprise Value | N/A |
CymaBay Therapeutics, Inc.'s stock has gained approximately 215.95331% over the past 52 weeks. The 50-day moving average sits at 28.59, while the 200-day moving average is 18.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | 215.95331% |
| 50-Day Moving Average | 28.59 |
| 200-Day Moving Average | 18.42 |
| Average Volume (20 Days) | N/A |